Study illuminates sugar’s role in common kidney disease


A study of kidney organoids in a novel lab environment might have downstream implications for the treatment of polycystic kidney disease (PKD), an incurable condition that affects more than 12 million people worldwide.

New research shows genetic effect on the response to treatment for obesity

Previous article

Pharmacotyping of childhood leukemia provides a blueprint for ‘true precision medicine’

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations